Metacare Co

Metacare Co Equity

The The Equity of Metacare Co (118000.KS) as of Nov 6, 2026 is 119.42 B KRW. In the previous year, The Equity was 116.80 B KRW — a change of 2.25% (higher).

Equity

119.42 BKRW

YoY

2.25%

Last updated:

In 2025, Metacare Co's equity was 119.42 B KRW, a 2.25% increase from the 116.80 B KRW equity in the previous year.

The Metacare Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
18.39 B KRW
Jan 1, 2019
35.82 B KRW
Jan 1, 2020
76.04 B KRW
Jan 1, 2021
119.40 B KRW
Jan 1, 2022
99.24 B KRW
Jan 1, 2023
105.91 B KRW
Jan 1, 2024
116.80 B KRW
Jan 1, 2025
119.42 B KRW
The Metacare Co Equity history
YEAREquityYoY
119.42 BKRW+2.25%
116.80 BKRW+10.28%
105.91 BKRW+6.72%
99.24 BKRW-16.88%
119.40 BKRW+57.02%
76.04 BKRW+112.30%
35.82 BKRW+94.76%
18.39 BKRW-0.71%
18.52 BKRW+37.85%
13.44 BKRW+117.22%
6.19 BKRW-24.24%
8.16 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Metacare Co Stock analysis

What does Metacare Co do? Metacare Co Ltd generates revenue through five business segments. The Pharmaceuticals Business segment distributes pharmaceuticals such as recapsules and tablets. The Medical Business segment sells medical devices and supplies. The Wireless Device segment manufactures wearable wireless devices. The Video Content segment produces video products. The Investment segment provides management consulting and investment services. These segments serve healthcare providers, medical institutions, and corporate clients seeking healthcare solutions and technology products. The company's products include recapsules, tablets, medical devices, medical supplies, wearable wireless devices, and video products. Brands mentioned are not specified in the business description. The target customers are healthcare providers, medical institutions, and corporate clients. The Investment segment's clients include businesses requiring management consulting and investment services. Revenue streams come from the sale of pharmaceuticals, medical devices, wearable devices, video content, and consulting services. The Wireless Device segment's wearable wireless devices are sold to consumers and businesses. The Video Content segment's video products are distributed to various channels. The Investment segment's management consulting and investment services are contracted by corporate clients. Metacare Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Metacare Co's Equity

Metacare Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Metacare Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Metacare Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Metacare Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Metacare Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Metacare Co stock

The Equity of Metacare Co is 119.42 B KRW in 2025.

The Equity of Metacare Co changed from 116.80 B KRW to 119.42 B KRW, representing a 2.25% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Metacare Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Metacare Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Metacare Co

All Key Metrics — Metacare Co